<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04853680</url>
  </required_header>
  <id_info>
    <org_study_id>2020-12-023-001</org_study_id>
    <nct_id>NCT04853680</nct_id>
  </id_info>
  <brief_title>Effect of Anti-adhesion Barrier on the Voice Quality After Thyroidectomy.</brief_title>
  <official_title>A Prospective Randomized Controlled Study of Whether Anti-adhesion Barrier Can Prevent Voice Quality After Thyroidectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inha University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inha University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether the use of anti-adhesion barrier after thyroid surgery can prevent the&#xD;
      voice changes after surgery, using objective voice-related indicators.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Randomized controlled study&#xD;
&#xD;
        -  Including 40 patients in each arm&#xD;
&#xD;
        -  Treatment: anti-adhesion barrier apply on the thyroidectomy space&#xD;
&#xD;
        -  Control: No use of anti-adhesion barrier&#xD;
&#xD;
        -  Primary outcome: VHI-30 (Voice handicap index)&#xD;
&#xD;
        -  Secondary outcome: findings from stroboscopy, CSL (Computerize Speech Lab)&#xD;
&#xD;
        -  Outcome measurement: preoperative, post-operative 3 months, post-operative 9 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">July 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Treatment: Use of Anti-adhesion barrier on the thyroidectomy space Control: No use of anti-adhesion barrier</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants do not know about the use of anti-adhesion agents.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Voice Handicap Index - 30 (VHI-30)</measure>
    <time_frame>Preoperative 1 day</time_frame>
    <description>Overall score of VHI (Total 30 points)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Voice Handicap Index - 30 (VHI-30)</measure>
    <time_frame>Postoperative 3 months</time_frame>
    <description>Overall score of VHI (Total 30 points)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Voice Handicap Index - 30 (VHI-30)</measure>
    <time_frame>Postoperative 9 months</time_frame>
    <description>Overall score of VHI (Total 30 points)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Voice range profile (VRP)</measure>
    <time_frame>Preoperative 1 day, Post-operative 3 months, Post-operative 9 months.</time_frame>
    <description>Mininum Hz, Maximal Hz</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GRBAS score</measure>
    <time_frame>Preoperative 1 day, Post-operative 3 months, Post-operative 9 months.</time_frame>
    <description>Grade, Rough, Breathy, Asthenic, Strained score. (0-3 points in each parameter)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Thyroid Nodule</condition>
  <condition>Thyroid Cancer</condition>
  <condition>Voice Disorders</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of Anti-adhesion barrier on the thyroidectomy space. After the thyroidectomy, anti-adhesion barrier will be applied on the thyroidectomy space, around the trachea, cricothyroid muscle and platysma muscle before the closure of surgical wound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No use of anti-adhesion barrier. After the thyroidectomy, don't use the anti-adhesion barrier before the wound closure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anti-adhesion barrier (Collarbarrier)</intervention_name>
    <description>Collagen derived anti-adhesion barrier</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing open thyroidectomy for thyroid cancer&#xD;
&#xD;
          -  Patients whose tumor size is less than 4cm&#xD;
&#xD;
          -  Patients who are not suspected of surrounding organ involvement (T4) or metastasis to&#xD;
             central lymph nodes in preoperative imaging&#xD;
&#xD;
          -  Patients with no history of voice-related diseases prior to surgery&#xD;
&#xD;
          -  Patients with normal movement of both vocal cords in the preoperative vocal cord&#xD;
             examination&#xD;
&#xD;
          -  Patients who consented to the study and obtained consent for the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with uncontrolled high blood pressure, diabetes, chronic renal failure,&#xD;
             coagulation disease, etc.&#xD;
&#xD;
          -  History of cardiovascular disease (angina pectoris, heart failure, myocardial&#xD;
             infarction, cerebral infarction, cerebral hemorrhage, etc.)&#xD;
&#xD;
          -  Medical history of drug or substance disorder (alcohol, etc.)&#xD;
&#xD;
          -  Patients with diseases related to airways, esophagus, and vocal cords (vocal palsy,&#xD;
             vocal cord polyps, etc.)&#xD;
&#xD;
          -  Patients who have already had adhesions in the foreground due to radiation therapy or&#xD;
             surgery on the foreground in the past.&#xD;
&#xD;
          -  Patients with a history of keloid or hypertrophic scars&#xD;
&#xD;
          -  Patients planning to perform lateral cervical lymph node dissection&#xD;
&#xD;
          -  Patients with medical thyroid disease, such as Graves' disease and thyroid&#xD;
             inflammation in need of treatment&#xD;
&#xD;
          -  Pregnant or lactating female patients&#xD;
&#xD;
          -  Other patients who are in charge of clinical trials as unsuitable for participation in&#xD;
             the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jin Wook Yi, Professor</last_name>
    <phone>+82-32-890-3437</phone>
    <email>jinwook.yi@inha.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inha University Hospital</name>
      <address>
        <city>Incheon</city>
        <zip>22332</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Wook Yi, Dr.</last_name>
      <phone>+82-32-890-3437</phone>
      <email>jinwook.yi@inha.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 11, 2021</study_first_submitted>
  <study_first_submitted_qc>April 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inha University Hospital</investigator_affiliation>
    <investigator_full_name>Jin Wook Yi</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Thyroid Nodule</mesh_term>
    <mesh_term>Voice Disorders</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>In order to protect the privacy of patients, the original data of the study will not be disclosed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

